Kovacs Shane William Charles

Average Profitability
244.38%
Insider Buys Quantity
2
Insider Buys Sum
$34,173.00
Insider Sells Quantity
4
Insider Sells Sum
$4.86M

Insider Activity of Kovacs Shane William Charles

According to the SEC Form 4 filings, Kovacs Shane William Charles, being in a position of

  1. CH. OPERATING & FINANCIAL OFF. at Olema Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 18742 shares for $269,656,
    over all time since 2022-09-02, has bought 30000 shares for $34,173, and sold 18742 shares for $269,656.

The largest purchase of all time was on 2023-04-06 and amounted to 10000 shares of Olema Pharmaceuticals, Inc. for $34,173.

The largest sale of all time was on 2015-05-22 and amounted to 82491 share of PTC Therapeutics, Inc. for $4.57M.

Biography of Kovacs Shane William Charles

No biography is available at this moment.

2023-11-22SaleOlema Pharmaceuticals, Inc.
OLMA
CH. OPERATING & FINANCIAL OFF.
9,145
0.0169%
$13.89$127,024-13.6%
2023-11-21SaleOlema Pharmaceuticals, Inc.
OLMA
CH. OPERATING & FINANCIAL OFF.
9,597
0.0183%
$14.86$142,632-16.54%
2023-04-06PurchaseOlema Pharmaceuticals, Inc.
OLMA
CH. OPERATING & FINANCIAL OFF.
10,000
0.026%
$3.42$34,173+244.38%
2022-09-02PurchaseOlema Pharmaceuticals, Inc.
OLMA
CH. OPERATING & FINANCIAL OFF.
20,000
$0$0+18.16%
2015-05-22SalePTC Therapeutics, Inc.
PTCT
Chief Financial Officer
82,491
0.2473%
$55.41$4.57M-46.88%
2014-05-22SalePTC Therapeutics, Inc.
PTCT
Chief Financial Officer
1,650
0.0054%
$14.74$24,321+190.73%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.